Third, not all studies used standardized dosing of GLP-1RA therapy recommended in clinical practice (Table 1) and/or did not ensure that GLP-1RAs were at steady-state concentrations. Finally ...

ZT002 was safe and well tolerated in both biweekly and monthly dosing arms in patients with overweight or obesity with a tolerability profile aligned with the GLP-1RA class The presentation titled ...